Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product
Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product
Enrolling by invitation · NCT06925685 · Registry updated 2025-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Enrolling by invitation | Not stated | 2025-04-13 | NCT06925685 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Allogene Therapeutics | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Circuit Clinical | Buffalo | United States | 2 |